bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
1.630
-0.090 (-5.23%)
At close: Dec 5, 2025, 4:00 PM EST
1.720
+0.090 (5.52%)
After-hours: Dec 5, 2025, 7:55 PM EST
bioAffinity Technologies Market Cap
bioAffinity Technologies has a market cap or net worth of $7.32 million as of December 5, 2025. Its market cap has decreased by -64.68% in one year.
Market Cap
7.32M
Enterprise Value
333.56K
1-Year Change
-64.68%
Ranking
Category
Stock Price
$1.63
Market Cap Chart
Since the IPO on September 1, 2022, bioAffinity Technologies's market cap has decreased from $45.03M to $7.32M, a decrease of -83.74%. That is a compound annual growth rate of -42.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 7.32M | -48.37% |
| Dec 31, 2024 | 14.18M | 1.50% |
| Dec 29, 2023 | 13.97M | 4.34% |
| Dec 30, 2022 | 13.39M | -70.26% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |